← Back
$SPRO All transactions

Spero Therapeutics, Inc.

▼ SELL

$ Value

$88K

Shares

37,101

Price

$2

Filed

Feb 9

Insider

Name

Rajavelu Esther

Title

See Remarks

CIK

0001903716

Roles

Officer

Transaction Details

Transaction Date

2026-02-06

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

1,062,907

Footnotes

Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

Filing Info

Accession No.

0001193125-26-043336

Form Type

4

Issuer CIK

0001701108

Rajavelu Esther's History

Date Ticker Type Value
2026-02-06 SPRO $88K
2026-02-06 SPRO $120K
2026-02-02 SPRO A $0
2026-02-02 SPRO $41K
2026-02-02 SPRO A $0
2025-11-07 SPRO $95K
2025-05-02 SPRO A $0

Other Insiders at SPRO (90d)

Insider Bought Sold Last
Keutzer Timothy
Chief Operating Officer
$145K 2026-02-06
Rajavelu Esther
See Remarks
$160K 2026-02-06